Tapeworm Infection in Horses: Transmission, Diagnosis & Control

Equine tapeworms (Anoplocephala perfoliata, A. magna, Paranoplocephala mamillana) are common but often subclinical. They require an intermediate host—orbibatid mites—for transmission.

Life Cycle

1. Gravid proglottids passed in feces → disintegrate, releasing eggs.
2. Orbibatid mites (soil-dwelling) ingest eggs → oncospheres develop into cysticercoids in mite hemocoel (2–4 months).
3. Horse ingests infected mites while grazing → cysticercoids attach to ileocecal junction/ileum → mature in 6–10 weeks.

Clinical Significance

• Most infections asymptomatic.
• Heavy burdens → ileocecal intussusception, impaction colic, cecal perforation, weight loss, anemia.
• Mucosal erosion at attachment site → hemorrhage, ulceration.

Diagnosis

• Fecal flotation: Low sensitivity (intermittent shedding, heavy eggs don't float well).
• ELISA (serum/saliva): Detects anti-tapeworm antibodies; indicates exposure, not necessarily current burden. Commercial kits available (EquiSal).
• Fecal PCR: Emerging, higher sensitivity.

Treatment & Control

• Praziquantel: 1 mg/kg (often combined with ivermectin/moxidectin). Single dose; >95% efficacy.
• Pyrantel pamoate: 13.2 mg/kg (double dose) — less reliable for A. perfoliata.
• Strategic deworming: Treat annually (late fall/early winter) when mite ingestion peaks; target high-shedders identified by ELISA/FEC.
• Pasture management: Rotational grazing, manure removal, harrowing (dries mites).

Resistance to praziquantel not yet reported in equine tapeworms. FEC-directed selective therapy preserves refugia.